TY - JOUR T1 - Telling the truth: why disclosure matters in chronic kidney disease JF - British Journal of General Practice JO - Br J Gen Pract SP - 408 LP - 408 DO - 10.3399/bjgp12X653552 VL - 62 IS - 601 AU - David Gelipter Y1 - 2012/08/01 UR - http://bjgp.org/content/62/601/408.2.abstract N2 - Abdi et al’s editorial1 raises some important issues. Many patients with chronic kidney disease (CKD) are asymptomatic, but this differs from say, hypertension, in that end-organ damage has already occurred. Once disclosure has been made to a patient, as it should be, most would need to be guided through a risk assessment by their GP. The apposite appearance, in the same issue, of a paper on communicating risk to patients2 highlights … ER -